{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:00:10Z","timestamp":1780088410259,"version":"3.54.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Health Industry Scientific Research Program of Gansu Province","award":["GSWSKY2023-10"],"award-info":[{"award-number":["GSWSKY2023-10"]}]},{"name":"the Intra-Hospital Fund of the First Hospital of Lanzhou University","award":["ldyyyn2017-15"],"award-info":[{"award-number":["ldyyyn2017-15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06174-3","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:22:56Z","timestamp":1767176576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations"],"prefix":"10.1007","volume":"44","author":[{"given":"Yinzhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"issue":"1","key":"6174_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6174_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.eururo.2023.03.031","volume":"84","author":"S Remmers","year":"2023","unstructured":"Remmers S, Bangma CH, Godtman RA et al (2023) Relationship between baseline prostate-specific antigen on cancer detection and prostate cancer death: long-term follow-up from the European Randomized Study of Screening for Prostate Cancer. Eur Urol 84(5):503\u2013509. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.031","journal-title":"Eur Urol"},{"key":"6174_CR3","doi-asserted-by":"publisher","first-page":"e071082","DOI":"10.1136\/bmj-2022-071082","volume":"381","author":"A Vickers","year":"2023","unstructured":"Vickers A, O\u2019Brien F, Montorsi F et al (2023) Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit. BMJ 381:e071082. https:\/\/doi.org\/10.1136\/bmj-2022-071082From NLM","journal-title":"BMJ"},{"issue":"1","key":"6174_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13244-024-01699-4","volume":"15","author":"E Guo","year":"2024","unstructured":"Guo E, Xu L, Zhang D et al (2024) Diagnostic performance of MRI in detecting prostate cancer in patients with prostate-specific antigen levels of 4\u201310 ng\/mL: a systematic review and meta-analysis. Insights Imaging 15(1):147. https:\/\/doi.org\/10.1186\/s13244-024-01699-4From NLM","journal-title":"Insights Imaging"},{"issue":"12","key":"6174_CR5","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s00345-023-04613-7","volume":"41","author":"B Song","year":"2023","unstructured":"Song B, Song SH, Hwang SI et al (2023) Clinical value of prostate health index as an indicator for recommending magnetic resonance imaging in patients with gray-zone prostate-specific antigen level. World J Urol 41(12):3519\u20133526. https:\/\/doi.org\/10.1007\/s00345-023-04613-7From NLM","journal-title":"World J Urol"},{"issue":"1","key":"6174_CR6","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1038\/s41598-020-62015-w","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Dong B, Qu W et al (2020) Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the Gray zone. Sci Rep 10(1):5157. https:\/\/doi.org\/10.1038\/s41598-020-62015-wFrom NLM","journal-title":"Sci Rep"},{"key":"6174_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123005","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang J, Tang M, Lei XY, Li LC (2022) MRI-based radiomics nomogram for predicting prostate cancer with gray-zone prostate-specific antigen levels to reduce unnecessary biopsies. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics12123005","journal-title":"Diagnostics"},{"issue":"11","key":"6174_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1530\/erc-17-0438","volume":"25","author":"AT Aref","year":"2018","unstructured":"Aref AT, Vincent AD, O\u2019Callaghan ME et al (2018) The inverse relationship between prostate specific antigen (PSA) and obesity. Endocr Relat Cancer 25(11):933\u2013941. https:\/\/doi.org\/10.1530\/erc-17-0438","journal-title":"Endocr Relat Cancer"},{"key":"6174_CR9","doi-asserted-by":"publisher","first-page":"e929913","DOI":"10.12659\/msm.929913","volume":"27","author":"M Chen","year":"2021","unstructured":"Chen M, Ma T, Li J et al (2021) Diagnosis of prostate cancer in patients with prostate-Specific antigen (PSA) in the Gray area: construction of 2 predictive models. Med Sci Monit 27:e929913. https:\/\/doi.org\/10.12659\/msm.929913From NLM","journal-title":"Med Sci Monit"},{"issue":"4","key":"6174_CR10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230643","volume":"307","author":"V Goh","year":"2023","unstructured":"Goh V (2023) PI-RADS and multiparametric MRI: the shape of things to come for prostate cancer. Radiology 307(4):e230643. https:\/\/doi.org\/10.1148\/radiol.230643","journal-title":"Radiology"},{"issue":"9","key":"6174_CR11","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1007\/s00330-024-10626-6","volume":"34","author":"AR Padhani","year":"2024","unstructured":"Padhani AR, Godtman RA, Schoots IG (2024) Key learning on the promise and limitations of MRI in prostate cancer screening. Eur Radiol 34(9):6168\u20136174. https:\/\/doi.org\/10.1007\/s00330-024-10626-6From NLM","journal-title":"Eur Radiol"},{"key":"6174_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16172951","author":"A Antolin","year":"2024","unstructured":"Antolin A, Roson N, Mast R et al (2024) The role of radiomics in the prediction of clinically significant prostate cancer in the PI-RADS v2 and v2.1 era: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16172951","journal-title":"Cancers (Basel)"},{"key":"6174_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061128","author":"LM Huynh","year":"2023","unstructured":"Huynh LM, Hwang Y, Taylor O, Baine MJ (2023) The use of MRI-derived radiomic models in prostate cancer risk stratification: a critical review of contemporary literature. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics13061128","journal-title":"Diagnostics"},{"key":"6174_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.825429","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, Sun L, Li Q et al (2021) Development and validation of a radiomics nomogram for predicting clinically significant prostate cancer in PI-RADS 3 lesions. Front Oncol 11:825429. https:\/\/doi.org\/10.3389\/fonc.2021.825429","journal-title":"Front Oncol"},{"issue":"4","key":"6174_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/jmri.28505","volume":"57","author":"X Li","year":"2023","unstructured":"Li X, Li C, Chen M (2023) Patients with \u201cgray zone\u201d PSA levels: application of prostate MRI and MRS in the diagnosis of prostate cancer. J Magn Reson Imaging 57(4):992\u20131010. https:\/\/doi.org\/10.1002\/jmri.28505","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"6174_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"key":"6174_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040810","author":"G Feretzakis","year":"2024","unstructured":"Feretzakis G, Julieb\u00f8-Jones P, Tsaturyan A et al (2024) Emerging trends in AI and radiomics for bladder, kidney, and prostate cancer: a critical review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16040810","journal-title":"Cancers (Basel)"},{"key":"6174_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1225490","volume":"13","author":"M Mehmood","year":"2023","unstructured":"Mehmood M, Abbasi SH, Aurangzeb K, Majeed MF, Anwar MS, Alhussein M (2023) A classifier model for prostate cancer diagnosis using CNNs and transfer learning with multi-parametric MRI. Front Oncol 13:1225490. https:\/\/doi.org\/10.3389\/fonc.2023.1225490","journal-title":"Front Oncol"},{"issue":"12","key":"6174_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/rli.0000000000001102","volume":"59","author":"C Roest","year":"2024","unstructured":"Roest C, Yakar D, Rener Sitar DI et al (2024) Multimodal AI combining clinical and imaging inputs improves prostate cancer detection. Invest Radiol 59(12):854\u2013860. https:\/\/doi.org\/10.1097\/rli.0000000000001102From NLM","journal-title":"Invest Radiol"},{"issue":"6","key":"6174_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.15672","volume":"8","author":"JJ Twilt","year":"2025","unstructured":"Twilt JJ, Saha A, Bosma JS et al (2025) AI-assisted vs unassisted identification of prostate cancer in magnetic resonance images. JAMA Netw Open 8(6):e2515672. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.15672","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6174_CR21","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1038\/s41598-024-84516-8","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wang R, Fang Z, Tang J (2025) Feasibility study of AI-assisted multi-parameter MRI diagnosis of prostate cancer. Sci Rep 15(1):10530. https:\/\/doi.org\/10.1038\/s41598-024-84516-8From NLM","journal-title":"Sci Rep"},{"issue":"7","key":"6174_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25(7):879\u2013887. https:\/\/doi.org\/10.1016\/s1470-2045(24)00220-1","journal-title":"Lancet Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06174-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:24:41Z","timestamp":1767227081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6174"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06174-3","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the First Hospital of Lanzhou University (Approval No.LDYYLL2025-814), and the requirement for patient informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"73"}}